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Abstract
Background: Leiomysarcoma of intravascular origin is an exceedingly rare entity of malignant soft tissue tumors.
They are most frequently encountered in the retroperitoneum arising from the inferior vena cava and are scarcely
found to arise from vessels of the extremities. These tumors were analysed with particular reference to treatment
outcome and prognosis. The aim of this article is to broaden the knowledge of the clinical course of this rare
malignancy.
Method: During 2000 and 2009 twelve patients were identified with an intravascular origin of a leiomyosarcoma.
Details regarding the clinical course, follow-up and outcome were assessed with focus on patient survival, tumor
relapse and metastases and treatment outcome. 3 year survival probability was calculated using Kaplan-Meier
method.
Results: Vascular leiomyosarcomas accounted for 0.7% of all malignant soft tissue tumors treated at our soft tissue
sarcoma reference center. The mean follow up period was 38 months. Tumor relapse was encountered in six
patients. 6 patients developed metastatic disease. The three year survival was 57%.
Conclusion: Vascular leiomysarcoma is a rare but aggressive tumor entity with a high rate of local recurrence and
metastasis.
Background
Malignant soft tissue tumors account for < 1% of malig-
nant tumors in adults [1], Leiomyosarcomas make up
only < 5% of these rare soft tissue tumors [2].
Intraabdominal, retroperitoneal, cutaneous, subcuta-
neous and vascular growth patterns can be distin-
guished. Vascular leiomyosarcoma arises from major
b l o o dv e s s e l sa n do r i g i n a t e s directly from the muscular
wall of these vessels.
Up to 75% [3] arise from the retroperitoneal course of
the inferior vena cava [4]. As with other soft tissue sar-
comas clinical presentation may be delayed due to their
deep origin. Presentation include palpable masses or
intraluminal obstruction with signs of venous stases,
thrombosis or embolism. Extracaval venous branches are
a particularly rare source of vascular leiomyosarcomas
and most frequently involve venous branches of the
lower extremity [4]. Due to its rare incidence and the
unusual clinical course the diagnosis and special treat-
ment requirements are often challenging for the multi-
disciplinary team. We reviewed our experience with
vascular leiomysarcomas with special reference to the
clinical course and outcome. Differential diagnosis, clini-
cal and pathological criteria will be discussed.
Methods and Materials
A search of our prospectively updated soft tissue tumor
database revealed 182 patients diagnosed with a leio-
myosarcoma from 2000 to 2009 at the BG University
Hospital Bergmannsheil. Twelve of these tumors had an
intravascular origin. Patients’ notes were evaluated and
patients and their physicians were contacted for details
regarding the clinical course, follow-up and outcome.
Follow-up imagine was obtained for all patients and
included chest X-ray or CT scan, abdominal ultrasound,
CT or MRI scan of the tumor site.
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primary tumor resection site and metastatic disease was
defined as tumor growth at any other site. Results are
presented as means and standard deviation. Three year
survival was calculated using the Kaplan - Meier
method.
Due to the small number of patients we refrained
from further statistical analysis.
Histology
Histological slides of the primary tumor were (re-)
assessed by a pathologist* with expertise in soft tissue
pathology from the Institute of Pathology, BG University
Hospital Bergmannsheil. In all cases additional immuno-
histochemistry was performed to confirm the diagnosis.
Second expert opinions from another pathologists were
obtained in two cases. The primary diagnosis of an
intravascular leiomyosarcoma of our institute was con-
firmed in both cases.
*The histopathological assessment by Prof. C.Kuhnen
was carried out predominantly during his time at
the Institute of Pathology, BG-University-Hospital
“Bergmannsheil”, Ruhr-University, Bochum, Germany
Results
1613 patients with a malignant soft tissue tumor (MSTT)
were treated at our institute between 2000 and 2009. 182
tumors (11% of all MSTT) were diagnosed as leiomyosar-
coma. Twelve of these tumors were of intravascular ori-
gin. Intravascular leiomyosarcoma accounted for 0.7% of
all MSTT or 6% of all leiomyosarcomata. The mean age
a tt h et i m eo fd i a g n o s i sw a s5 9y e a r s( ±1 0 . 7 ) .N i n e
patients were females and three were males. The mean
follow-up time from the time of definite surgery of the
primary tumor was 38 months (± 30.6). The three year
survival was 57%. Due to the insidious onset of the dis-
ease and late clinical symptoms the time between onset
of tumor growth and the definite diagnosis could not be
assessed.
The site of tumor growth was the lower extremity
in 67%, the upper extremity in 25% and the vena cava
in 8%.
In 50% the disease initially presented with signs of
venous stasis. Deep venous thrombosis (n = 1), throm-
bophlebitis of the long saphenous vein (n = 2) and acute
pulmonary embolism (n = 1) occurred as initial symp-
toms of the malignancy.
67% of the tumors were subfascial and 25% epifascial.
In 33% the tumor originated from the femoral vein.
Mean tumor size was 7.4 cm in largest diameter (± 3.0).
17% of the tumors were TI and 83% were TII.
At primary diagnosis no metastatic disease was
detected in any patient.
According to the Coindre classification of tumor grad-
ing for soft tissue tumors, the tumors were subdivided
in high grade (42%), intermediate (42%) and low grade
(16%). (Table 1)
Primary diagnosis was provided by incisional biopsy in
two cases and punch biopsy in a further two cases prior
to surgical ablation. Five patients were resected with
microscopically positive margins at other institutes and
were referred to our center for definitive ablation. One
patient presented with the clinical symptoms of a wrist
ganglion. After the initial tumor resection the histologi-
cal assessment revealed a vascular leiomyosarcoma. The
definite surgical intervention required a resection of the
ulnar artery and accompanying vena comitantes. Two
patients were transferred to our center after tumor
relapse. One of them initially underwent vascular bypass
s u r g e r yf o ras u s p e c t e dm a l i gnant fibrous histiocytoma
(N
O. 2). The initial incorrect pathological assessment
was benign. Tumor relapse led to the diagnosis of aleio-
mysarcoma. At that time the tumor surrounded the vas-
cular prosthesis and hip implant. Amputation was
discussed but refused by the patient. Palliative radiation
therapy was initiated and the patient died five months
later. In the other patient (N
O. 12) during stripping of
the long saphenous vein a tumor mass was encountered
and the surgical specimen was sent for histology which
demonstrated a leiomyosarcoma. The tumor was
resected with positive margins. Despite adjuvant radia-
tion therapy the tumor relapsed. The patient was then
admitted to an oncology department where he received
adjuvant chemotherapy before being transferred to our
center for intervention. Surgery with curative intent
required an extended hip amputation. At present there
is no evidence of metastatic disease after 14 months.
Three patients had femoral vessel resection and a sub-
sequent arterial bypass.
Patient N
O. 7 required partial resection of the vessel
wall of the inferior vena cava. In N
O. 11&12 the tumor
bearing segment of the long saphenous vein was
resected. The ulnar artery and vein were resected in one
patient.
Six patients received adjuvant radiation therapy of the
primary tumor bed with a dose of 60 - 72 Gy. Three
(N
O. 2,4&9) of these patients died of the disease, one of
them (N
O. 2) received radiation therapy with palliative
intention and one (N
O. 4) had microscopically positive
resection margins after surgical ablation.
Six patients (N
O.1; 2; 4; 9; 11 & 12) developed pulmonary
metastasis, one patient also suffered from bone metastasis
(N
O.9), another one (N
O.11) had additional liver metastasis.
Five of these patients (N
O.1;2;9;11 & 12) also developed
recurrent disease. In further two patients (N
O.1;2) pulmon-
ary metastasis was suspected approximately 6 (N
O.1) and 4
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O.2) months after the definite operation but according to
the patients’ wishes no tests were done to confirm the
metastatic disease. All but two (N
O.11 & 12) patients with
metastatic disease died (N
O.1 eighteen months N
O.2s i x
months N
O4 ten months and N
O9t w e n t ye i g h tm o n t h s
after the final diagnosis was made). One patient received
neoadjuvant chemotherapy (N
O.9).
Five of these patients sought palliative chemotherapy
(N
O. 1, 4,10,11 & 12). Table 2
Macroscopic appearance
In all cases tumor growth in close proximity to vascular
structures was present. On resection of the tumor
bearing vessels the tumors were found to originate from
structures of the vessels walls and to exhibit an intravas-
cular tumor sprout. Figure 1
Microscopic appearance of the tumor
Histologically a spindle cell, mesenchymal neoplasm was
found in all cases associated with the media of the vessel
wall, which was assessed as site of tumor origin. The
tumor cells were characteristically forming various fasci-
cles and showed an eosinophilic cytoplasm with cigar
shaped nuclei. Figure 2
T h en e o p l a s md e r i v e df r o mt h em e d i ao ft h ev e s s e l
wall and disrupted the existing vascular architecture.
Table 1 Data of the patient collective and clinical course of the tumor disease
Patient Age at
the time
of diag.
Localisation Affected
vessel
Size in cm TNM Comments Thrombembolic
event
Status
1 66 right upper
extremity,
supra-
clavicula
region
internal
Jugular vein/
sub-clavian
vein
7.6 × 8 ×
3.3
T2 N0
M0
G2
second expert opinion n DOD
2 74 left thigh femoral vein - – no diagnosis before primary surgery n DOD
3 77 Left upper
extremity,
wrist
accompaniing
ulna vein
2.7×1.7×1.2 T1 N0
M0
G1
initial surgery for a suspected wrist
ganglion revealed the diagnosis of a
intravascular leiomyosarcoma
n alive
4 52 right thigh femoral vein 6.4 × 7 ×
9
T2 N0
M0
G3
palpable tumor 4 month before
diagnosis
n DOD
5 55 left dorsum
of the upper
arm
subcutaneous
Vein
7.8 × 4.5 ×
5
T2 N0
M0
G3
palpable tumor 2 month before
diagnosis
n alive
6 64 right thigh subcutaineous
vein
2.5 × 2 ×
1
T1 N0
M0
G2
palpable tumor 3-4 month before
diagnosis; external primary tumor
enucliation
second expert opinion
n alive
7 41 retro-
peritoneum
inferior vena
cava
8.8 × 6 ×
5
T2 N0
M0
G1
primary histology Pathol. BG-Uni.
Bergmannsheil Bochum; Second expert
opinion Oncological resection
Dep. Visceral Surg. Uni Bochum
n alive
8 56 right thigh external iliac
vein, femoral
vein
10.1 × 7.5
×5
T2 N0
M0
G2
3 tumor free lymph nodes in primary
histology
Oncological resection Dep. Visceral
Surg. Uni Bochum
deep vein throm-bosis alive
9 61 left thigh femoral vein 2.3 × 2 ×
6
T2 N0
M0
G2
- n DOD
10 59 left thigh femoral vein 9.6 × 6 ×
4
T2 N0
M0
G3
Histology was reassessed after
transferral due to a tumor relapse
pulmonary embo-lism alive
11 44 left thigh great
saphenous
vein
12 × 4 ×
3.6
T2 N0
M1
(lung,
liver)
G3
palpable small tumor, suspected to be
a lipoma two years prior to diagnosis
thrombophlebitis of
the saphenous vein
alive
12 56 left lower
leg
great
sahpenous
vein
5 × 4 × 1 T2N0
M1
(pulmo)
G3
crossectomy thrombophlebitis
preop., paget shrotter
syn-drome postop.
alive
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played a positive reaction for smooth muscle actin and
desmin, confirming smooth muscle differentiation of the
tumor. Figure 3
Discussion
Vascular leiomyosarcomata represent only a small pro-
portion of soft tissue leiomyosarcomata [4]. All publi-
cations in the literature are of small clinical series or
case reports. 11% of the patients treated for a malig-
nant soft tissue tumor at the BG University Hospital
Bergmannsheil presented with the leiomyosarcoma.
The vascular leiomyosarcomas accounted for 6% of
these tumors [5,6] Svarvar et al. recognised an even
sex distribution in his study of 225 patients with all
types of leiomyosarcoma [6].
In the current series nine patients with a vascular leio-
mysarcoma were female and three male. In the series of
patients with vascular leiomysarcoma from Berlin et al.
5 were males and 1 female [7], in Abed et al.´s group 9
were female and 7 male [5] and in Dzsinich et al.’ss e r -
ies 12 were female and 1 male [8].
These tumors mainly originate from the media of
venous vessel walls, with rare exceptions in which they
derive from the arterial vessel structures [9]. The tumor is
encountered in the retroperitoneal course of the inferior
vena cava in 75% of all intravascular leiomyosarcomata [3].
Table 2 Follow up data of the treatment related course
N
O. Age/
sex
Follow up period in
month
Untreated tumor
growth
Definite
proce-dure
Adjuvant radiation-
therapy
Chemo-
therapy
Local
recurrence
Meta-
stasis
Time to
death
1 66/f 18 - R0 - adjuvant 5 months lung 18 months
2 74/f 15 2years ? R1 60Gy - tumor-
progression
lung? 15 months
3 77/m 84 - R0 - - - - alive
4 52/f 10 2 month R1 60Gy - - lung 10 months
5 55/f 82 - R0 60Gy adjuvant 45 months - alive
6 64/m 78 4 month R0 - - - - alive
7 41/f 64 - R0 - - - - alive
8 56/f 43 - R0 60Gy - - - alive
9 61/f 28 - R0 60Gy - 25 months lung/
bone
28
months
10 59/m 7 immediate R1 - neo-
adjuvant
2 months - alive
11 44/f 14 2 years R0 - adjuvant 12 months lung/
liver
alive
12 56/f 14 - R0 72Gy adjuvant 10 months lung alive
Figure 1 Macroscopic appearance of a leiomysarcoma
specimen after tumor resection at the wrist.
Figure 2 Histological appearance of a leiomyosarcoma after
resection of a tumor in the subclavicular region. Notice the
“cigar shaped” configuration of tumor cell nuclei with nuclear atypia
(H&E staining).
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tumors.
Venous obstruction and a palpable tumor mass were
the most common symptoms. Deep venous thrombosis
and even pulmonary embolism may be the initial clinical
symptoms and can camouflage the clinical manifestation
disease [10].
Leiomyosarcomas arising form smaller vessels are less
frequent and may present primarily as nerve compres-
sion syndrome [4]. These tumors often protrude
through small lumina of adjacent venous branches [7].
One of the patients presented with symptoms of arterial
occlusion requiring vascular bypass surgery. Unfortu-
nately in this particular case the delayed diagnosis in
conjunction with an incorrect pathological assessment
delayed the surgical ablation which permitted tumor
p r o g r e s s i o n .A tt h i sl a t et i m ep o i n tt ot h ep a t i e n t
refused surgical ablation and instead sought palliative
radiation therapy.
Venous branches of the lower extremity as well as the
azygos vein have been described as unusual sites of
manifestation of intravascular leiomyosarcomata in the
current literature [11,12]. Tumors localised in the upper
extremity or the head and neck region are rare exemp-
tions with reports in the literature limited to single
cases [3,13-15]. In our intravascular leiomyosarcomas of
the extremities there were four patients with a tumor
origin of the femoral vein, further two cases of larger
subcutaneous vein branches of the thigh, two of the
long saphenous vein and most interestingly, three
patients where the tumor was found in the upper extre-
mity. Similar to our findings Berlin et al. [7] and Abed
et al. [5] described the majority of these vascular leio-
myosarcomas as arising from the lower extremity. In the
combined studies of Abed et al. [5] and Dzsinich et al.
[8] and Berlin et al. only one tumor was found in the
upper extremity [7].
It has been indicated that small vein structures are the
predominant source of the rare intravascular leiomyo-
sarcomata of the deep somatic soft tissue [16].
The clinical picture may either result form the tumor
growth itself or be related to the vascular occlusion
manifesting as venous stases or thrombosis. A wide
range of differential diagnosis may lead to clinical symp-
toms of venous stasis in the upper and lower extremity
for example lung cancer, lymphomas, post thrombotic
syndrome [17]. Intravascular neoplasms result in stasis
of the blood flow by intraluminal obstruction [18,19].
CT scans, MRI, and angiograms [7,20] demonstrate fill-
ing defects in accordance with the clinical signs of vas-
cular compression are valuable diagnostic measures that
will facilitate the operative planning when suspecting an
intravascular leiomyosarcoma. Particularly MRI can
assist in differentiating intravascular tumor growth from
thrombosis. In contrast to the intravascular tumor a
thrombus commonly presents with a high signal inten-
sity both in the T1 and T2 weighted images whereas the
leiomyosarcoma appears as a homogenous tumor with
an intermediate signal intensity on T1 - weighted ima-
ging [21]. Moreover CT and MRI will not in all cases
allow for an exact image of the endovascular tumor
component [19].
An MRI was obtained in all of the presented patients
prior to surgical ablation. Two subcutaneous tumors
were ablated without imaging of the tumor prior to
transfer to our center. The MRI in these patients was
conducted before definitive surgery. A preoperative
angiogram even though desirable was performed only in
the minority of cases. Tumors of the venous vessel wall
may present with an intraluminal growth pattern or
may extent from the tunica media and infiltrate the sur-
rounding soft tissue [13]. In thin veins especially exten-
sion into the perivascular soft tissue may occur early [4].
As vascular leiomyosarcomata are commonly com-
p o s e do fa ni n t r a l u m i n a la sw e l la sa ne x t r a v a s c u l a r
tumor component [7] after biopsy diagnosis of a soft tis-
sue leiomyosarcoma the rare possibility of a primary
intravascular tumor growth has to be suspected since it
may influence the surgical strategy. Primary intravascu-
lar tumor growth may necessitate vascular dissection
and resection of the tumor bearing course over a longer
distance far from the palpable tumor mass due to intra-
luminal tumor extension [7,14]. The extravascular com-
ponent of the sarcomata sometimes requires the
resection and reconstruction of the adjacent artery as in
33% of the assessed patients.
In these cases both pre- and postoperative pulmonary
microthrombembolism are frequent complications
Figure 3 Intraluminal tumour growth of a Leiomyosarcoma
originating from great saphenous vein (GSV) (H&E-staining).
The subcutaneous adipose tissue is labelled SAT.
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lung also is the most common site of distant metastasis
[16]. Leiomyosarcomata are malignant tumors of
mesenchymal origin with a differention towards smooth
muscle morphology. The histological appearance is
composed of spindle shaped cells with eosinophilic
cytoplasm with muscular striation and cigar shaped
rounded nuclei. Immunohistochemical staining for con-
tractile fibers proteins such as actin, desmin as well as
h-caldesmon can verify the diagnosis. Standard H&E
staining and immunohistochemical staining for smooth
muscle markers was performed in all of the cases of this
series to confirm the diagnosis.
The differential diagnosis embraces the spectrum of
spindle cell shaped neoplasms such as benign and
malignant tumors of the nerve sheaths, myofibroblastic
tumors (myofibromatosis, fibromatosis, myofibroblastic
sarcoma), synovial sarcoma, fibrosarcoma and NOS
sarcoma [23].
Intimal sarcoma, malignant mesenchymal tumors of
the large arteries which originate from the intimal layer
of the vessel wall [24] and the very rare intravascular
angiosarcoma belong to the differential diagnosis of
malignant intravascular tumors [25].
Surgical ablation with clear margins is the therapy of
choice [5-7].
Vascular leiomyosarcomata are associated with aggres-
sive tumor growth, poorer prognosis and earlier onset of
metastatases compared to other soft tissue tumors [26].
The high rate of local recurrence and pulmonary metas-
tases seen in the present study confirm these findings.
Adjuvant radiation therapy may aid in local tumor con-
trol in the case of incomplete tumor resection or higher
tumor grade. Tumor size and localization are of prog-
nostic value [13]. Retroperitoneal leiomyosarcoma has
similar out come and prognosis to leiomyosarcoma of
the extremities [27].
Intravascular growth is associated with early pulmon-
ary metastasis [16]. The three year survival of 57% in
the presented study is consistant with the literature.
[5-7] We recommend to include all patients with leio-
myosarcomas in an international database to gain epide-
miological data and improve the treatment of these rare
tumors.
Conclusion
Leiomyosarcomas rarely arise from blood vessel walls.
The clinical presentation is misleading and thrombem-
bolic events may be the first symptoms. Intravascular
spread may complicate the surgical resection, rendering
it difficult to obtain clear margins. The extravenous
tumor component may necessitate resection of the
concomitant artery or vein which requires vascular
reconstruction. Early hematogenous metastasis and a
high rate of local recurrence compromise the prognosis
of the disease.
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